Related Experiment Videos
[Neonatal bacterial infections: magnitude and clinical aspects]
Abstract:
A prospective study on major bacterial infections (MBI) has been made over a six-month period in a neonatal unit. Incidence of MBI was 6.8 per 1,000 live births. Rates were significantly higher in low (57/1,000) and very low-birth-weight newborns (200/1,000). Septicemia occurred most frequently with group B hemolyticus streptococcus and staphylococcus aureus as the commonest infecting organisms. In 19/33 haematologic studies abnormal neutrophilic cell counts, thrombocytopenia or both were seen. Case/fatality rate was 50% in this series.
Insights
Major bacterial infections (MBI) affect 6.8/1,000 live births, with higher rates in premature infants. Group B Streptococcus and Staphylococcus aureus were common causes, and the case fatality rate was 50%.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatrics
Context:
- A six-month prospective study was conducted in a neonatal unit.
- Focus on major bacterial infections (MBI) in newborns.
- Assessing incidence and outcomes of neonatal infections.
Purpose:
- To determine the incidence of MBI in a neonatal unit.
- Identify common causative organisms and risk factors.
- Evaluate the case fatality rate of MBI.
Summary:
- The incidence of MBI was 6.8 per 1,000 live births.
- Rates were significantly higher in low (57/1,000) and very low-birth-weight newborns (200/1,000).
- Septicemia was frequent, with Group B hemolyticus streptococcus and Staphylococcus aureus as the most common pathogens. Hematologic abnormalities were noted in 19/33 cases, and the case/fatality rate was 50%.
Impact:
- Highlights the significant burden of MBI in neonatal populations.
- Identifies high-risk groups (low and very low-birth-weight infants) for targeted interventions.
- Underscores the severity of neonatal infections with a high case fatality rate, emphasizing the need for effective prevention and treatment strategies.